CAMBRIDGE, Mass. & BRISBANE, Queensland, Australia (BUSINESS WIRE) Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that the global
SK bioscience and Vaxxas Enter Joint Development Agreement for Needle-Free Patch Delivery of Typhoid Vaccine streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Funding from Wellcome will further broaden Vaxxas’ diverse clinical pipeline of next-generation vaccines to include Typhoid fever.Program will be jointly developed in collaboration with SK bioscience, a global leader in vaccine development.CAMBRIDGE, Mass. & BRISBANE, Queensland, Australia (BUSINESS WIRE) Vaxxas,.
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Fiji Times » South Korean activists protest against Fukushima water discharge fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.